Enzyme Replacement Therapy Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Sanofi, BioMarin, Alexion, Allergan, Johnson & Johnson

The global Enzyme Replacement Therapy market size is expected to grow at US$ 15,250.17 million in 2027 at a compound annual growth rate (CAGR) of 8.9%.

Enzyme Replacement Therapy Market Overview

Enzyme replacement therapy (ERT) is used to restore a missing or defective enzyme in a person with an inherited enzyme deficiency syndrome. Through the intravenous (IV) or oral modes of administration, it restores the body's depleted enzymes in the patient. The IV method, in which the replacement enzyme is given directly into the bloodstream via a regulated flow of fluids, is well-tolerated by patients. The increasing availability of enzyme replacement therapy, as well as increased awareness and less stringent standards for uncommon disorders, are major factors boosting market potential. The Genetic and Rare Diseases Information Center defines a rare disease as one that affects fewer than 200,000 people.  New therapeutic breakthroughs and increased product pipeline analyses are projected to give lucrative chances for the expansion of the enzyme replacement therapy market. Additionally, the demand for better healthcare services, significant government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging economies are all contributing to the significant growth of the healthcare sector in emerging economies.

Industry News and Updates:

August 6, 2021: FDA approves Nexviazyme (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease --

The U.S. Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person’s ability to move and breathe. Nexviazyme is an enzyme replacement therapy (ERT) designed to specifically target the mannose-6-phosphate (M6P) receptor, the key pathway for cellular uptake of enzyme replacement therapy in Pompe disease. Nexviazyme has been shown in clinical trials to provide patients with improvements in respiratory function and walking distance.

What are the major Applications, Types and Regions for Enzyme Replacement Therapy Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Injectable Agents


• Oral Agents

By Application, it is segmented into

• Gaucher Disease


• Fabry Disease


• MPS Disease


• Gastrointestinal Disease


• Others

Enzyme Replacement Therapy Market Regional Analysis

North America controls the worldwide enzyme replacement treatment market. Due to the expanding use of LSDs and the expansion of regulatory approval for products used in enzyme replacement treatment, the US currently holds the majority of the market share in the area. Treatment for the underlying enzyme deficiency that causes rare disorders including Gaucher, Fabry's, and Hunter's syndrome involves intravenous (IV) infusions. Because of this, there is an increasing need for discovering new treatments for these rare diseases. The European region accounted for the second-highest revenue after North America and is predicted to rise at a CAGR of 7.1%. The European region's healthcare system is publicly funded, and some nations have implemented universal health care systems. The presence of numerous patients with MPS and SCID is one of the key drivers of market expansion in the European region.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Enzyme Replacement Therapy Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Enzyme Replacement Therapy Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Enzyme Replacement Therapy Market report scope?

Key Takeaways from this Enzyme Replacement Therapy Market Report

• Evaluate Enzyme Replacement Therapy market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Enzyme Replacement Therapy market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Enzyme Replacement Therapy Market?

The Enzyme Replacement Therapy Market is growing at a CAGR of 8.9% over the next 5 years.

Who are the key players in Enzyme Replacement Therapy Market?

Sanofi, BioMarin, Alexion, Allergan, Johnson & Johnson, Recordati Rare Diseases, Abbvie Inc., Astrazeneca Plc, Biomarin Pharmaceutical In, Chiesi Farmaceutici S.P.A., Digestive Care, Inc., Leadiant Biosciences, Inc., Nestle Health Science, Pfizer Inc., Sanofi, Takeda Pharmaceuticals, Horizon Pharma Public Limited Company, Actelion (Janssen), Recordati Rare Diseases, Protalix Biotherapeutics, Amicus Therapeutics, Inc.

What are the significant types of Enzyme Replacement Therapy Market?

Injectable Agents, Oral Agents

What are the major end-use applications of Enzyme Replacement Therapy Market?

Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.